[HTML][HTML] Effectiveness of molnupiravir vs nirmatrelvir-ritonavir in non-hospitalised and hospitalised patients with COVID-19: a target trial emulation study
Background Molnupiravir and nirmatrelvir-ritonavir have emerged as promising options for
COVID-19 treatment, but direct comparisons of their effectiveness have been limited. This …
COVID-19 treatment, but direct comparisons of their effectiveness have been limited. This …
[PDF][PDF] Effectiveness of molnupiravir vs nirmatrelvir-ritonavir in non-hospitalised and hospitalised patients with COVID-19: a target trial emulation study
EYF Wan, VKC Yan, ZCT Wong, CSL Chui, FTT Lai… - 2023 - scienceopen.com
Background Molnupiravir and nirmatrelvir-ritonavir have emerged as promising options for
COVID-19 treatment, but direct comparisons of their effectiveness have been limited. This …
COVID-19 treatment, but direct comparisons of their effectiveness have been limited. This …
Effectiveness of molnupiravir vs nirmatrelvir-ritonavir in non-hospitalised and hospitalised patients with COVID-19: a target trial emulation study
E Wan, V Yan, Z Wong, C Chui, F Lai, X Li… - …, 2023 - europepmc.org
Background Molnupiravir and nirmatrelvir-ritonavir have emerged as promising options for
COVID-19 treatment, but direct comparisons of their effectiveness have been limited. This …
COVID-19 treatment, but direct comparisons of their effectiveness have been limited. This …
Effectiveness of molnupiravir vs nirmatrelvir-ritonavir in non-hospitalised and hospitalised patients with COVID-19: a target trial emulation study
EYF Wan, VKC Yan, ZCT Wong, CSL Chui, FTT Lai… - …, 2023 - hub.hku.hk
Background: Molnupiravir and nirmatrelvir-ritonavir have emerged as promising options for
COVID-19 treatment, but direct comparisons of their effectiveness have been limited. This …
COVID-19 treatment, but direct comparisons of their effectiveness have been limited. This …
[HTML][HTML] Effectiveness of molnupiravir vs nirmatrelvir-ritonavir in non-hospitalised and hospitalised patients with COVID-19: a target trial emulation study
EYF Wan, VKC Yan, ZCT Wong, CSL Chui, FTT Lai… - eClinicalMedicine, 2023 - Elsevier
Background Molnupiravir and nirmatrelvir-ritonavir have emerged as promising options for
COVID-19 treatment, but direct comparisons of their effectiveness have been limited. This …
COVID-19 treatment, but direct comparisons of their effectiveness have been limited. This …
[HTML][HTML] Effectiveness of molnupiravir vs nirmatrelvir-ritonavir in non-hospitalised and hospitalised patients with COVID-19: a target trial emulation study
EYF Wan, VKC Yan, ZCT Wong, CSL Chui… - …, 2023 - ncbi.nlm.nih.gov
Background Molnupiravir and nirmatrelvir-ritonavir have emerged as promising options for
COVID-19 treatment, but direct comparisons of their effectiveness have been limited. This …
COVID-19 treatment, but direct comparisons of their effectiveness have been limited. This …
Effectiveness of molnupiravir vs nirmatrelvir-ritonavir in non-hospitalised and hospitalised patients with COVID-19: a target trial emulation study
EYF Wan, VKC Yan, ZCT Wong… - …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Molnupiravir and nirmatrelvir-ritonavir have emerged as promising options for
COVID-19 treatment, but direct comparisons of their effectiveness have been limited. This …
COVID-19 treatment, but direct comparisons of their effectiveness have been limited. This …
Effectiveness of molnupiravir vs nirmatrelvir-ritonavir in non-hospitalised and hospitalised patients with COVID-19: a target trial emulation study.
EYF Wan, VKC Yan, ZCT Wong, CSL Chui… - …, 2023 - europepmc.org
Background Molnupiravir and nirmatrelvir-ritonavir have emerged as promising options for
COVID-19 treatment, but direct comparisons of their effectiveness have been limited. This …
COVID-19 treatment, but direct comparisons of their effectiveness have been limited. This …